Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2011 | 855 Thousand USD | -31.55% |
| 2010 | 1.24 Million USD | 28.5% |
| 2009 | 972 Thousand USD | -42.04% |
| 2008 | 1.67 Million USD | -12.97% |
| 2007 | 1.92 Million USD | 18.29% |
| 2006 | 1.62 Million USD | -34.37% |
| 2005 | 2.48 Million USD | 10.95% |
| 2004 | 2.23 Million USD | -50.82% |
| 2003 | 4.54 Million USD | -62.95% |
| 2002 | 12.27 Million USD | -0.12% |
| 2001 | 12.29 Million USD | 8.44% |
| 2000 | 11.33 Million USD | 146.41% |
| 1999 | 4.6 Million USD | 39.39% |
| 1998 | 3.3 Million USD | 6.45% |
| 1997 | 3.1 Million USD | 121.43% |
| 1996 | 1.4 Million USD | 27.27% |
| 1995 | 1.1 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2011 FY | 855 Thousand USD | -31.55% |
| 2010 FY | 1.24 Million USD | 28.5% |
| 2009 Q1 | 238 Thousand USD | -43.6% |
| 2009 FY | 972 Thousand USD | -42.04% |
| 2008 FY | 1.67 Million USD | -12.97% |
| 2008 Q1 | 493 Thousand USD | -8.02% |
| 2008 Q4 | 422 Thousand USD | 36.57% |
| 2008 Q3 | 309 Thousand USD | -31.33% |
| 2008 Q2 | 450 Thousand USD | -8.72% |
| 2007 FY | 1.92 Million USD | 18.29% |
| 2007 Q4 | 536 Thousand USD | 24.65% |
| 2007 Q2 | 594 Thousand USD | 61.41% |
| 2007 Q1 | 368 Thousand USD | 127.16% |
| 2007 Q3 | 430 Thousand USD | -27.61% |
| 2006 Q4 | 162 Thousand USD | -68.3% |
| 2006 Q2 | 503 Thousand USD | 11.28% |
| 2006 FY | 1.62 Million USD | -34.37% |
| 2006 Q1 | 452 Thousand USD | 33.73% |
| 2006 Q3 | 511 Thousand USD | 1.59% |
| 2005 Q4 | 338 Thousand USD | -49.25% |
| 2005 FY | 2.48 Million USD | 10.95% |
| 2005 Q2 | 825 Thousand USD | 27.31% |
| 2005 Q3 | 666 Thousand USD | -19.27% |
| 2005 Q1 | 648 Thousand USD | 376.47% |
| 2004 FY | 2.23 Million USD | -50.82% |
| 2004 Q4 | 136 Thousand USD | -78.65% |
| 2004 Q3 | 637 Thousand USD | 39.69% |
| 2004 Q2 | 456 Thousand USD | -36.31% |
| 2004 Q1 | 716 Thousand USD | -30.01% |
| 2003 Q1 | 1.08 Million USD | -67.54% |
| 2003 FY | 4.54 Million USD | -62.95% |
| 2003 Q4 | 1.02 Million USD | 45.11% |
| 2003 Q3 | 705 Thousand USD | -59.53% |
| 2003 Q2 | 1.74 Million USD | 61.3% |
| 2002 Q2 | 2.36 Million USD | -14.55% |
| 2002 Q3 | 3.82 Million USD | 62.05% |
| 2002 FY | 12.27 Million USD | -0.12% |
| 2002 Q4 | 3.32 Million USD | -13.04% |
| 2002 Q1 | 2.76 Million USD | -30.46% |
| 2001 Q4 | 3.97 Million USD | 21.31% |
| 2001 FY | 12.29 Million USD | 8.44% |
| 2001 Q3 | 3.27 Million USD | 27.09% |
| 2001 Q2 | 2.57 Million USD | 3.37% |
| 2001 Q1 | 2.49 Million USD | -29.97% |
| 2000 Q4 | 3.56 Million USD | 64.06% |
| 2000 FY | 11.33 Million USD | 146.41% |
| 2000 Q1 | 1.95 Million USD | -6.76% |
| 2000 Q2 | 2.91 Million USD | 48.83% |
| 2000 Q3 | 2.17 Million USD | -25.53% |
| 1999 Q1 | 800 Thousand USD | -38.46% |
| 1999 Q4 | 2.1 Million USD | 90.91% |
| 1999 Q2 | 600 Thousand USD | -25.0% |
| 1999 FY | 4.6 Million USD | 39.39% |
| 1999 Q3 | 1.1 Million USD | 83.33% |
| 1998 FY | 3.3 Million USD | 6.45% |
| 1998 Q4 | 1.3 Million USD | 116.67% |
| 1998 Q3 | 600 Thousand USD | -25.0% |
| 1998 Q2 | 800 Thousand USD | 33.33% |
| 1998 Q1 | 600 Thousand USD | -25.0% |
| 1997 Q1 | 700 Thousand USD | 0.0% |
| 1997 Q4 | 800 Thousand USD | 0.0% |
| 1997 Q3 | 800 Thousand USD | 60.0% |
| 1997 FY | 3.1 Million USD | 121.43% |
| 1997 Q2 | 500 Thousand USD | -28.57% |
| 1996 Q3 | 500 Thousand USD | 66.67% |
| 1996 Q1 | - USD | 0.0% |
| 1996 FY | 1.4 Million USD | 27.27% |
| 1996 Q2 | 300 Thousand USD | 0.0% |
| 1996 Q4 | 700 Thousand USD | 40.0% |
| 1995 Q4 | - USD | 100.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 FY | 1.1 Million USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q3 | -1.4 Million USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 70.14% |
| Ansell Limited | 495.5 Million USD | 99.827% |
| Ansell Limited | 495.5 Million USD | 99.827% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | 98.967% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | 50.6% |
| Psykey, Inc. | 1.21 Million USD | 29.541% |
| ConvaTec Group Plc | 910.31 Million USD | 99.906% |
| ConvaTec Group Plc | 872.5 Million USD | 99.902% |
| Encision Inc. | 3.77 Million USD | 77.361% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -502.915% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -677.761% |
| Innovative MedTech Inc. | 6.09 Million USD | 85.981% |
| LifePoint, Inc. | 7.42 Million USD | 88.483% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 86.533% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -17.747% |
| Reflect Scientific, Inc. | 1.06 Million USD | 19.62% |
| SmileDirectClub, Inc. | 517 Million USD | 99.835% |
| Sector 10, Inc. | 39.84 Thousand USD | -2045.869% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 99.987% |
| SheerVision, Inc. | 2.33 Million USD | 63.33% |
| United Health Products, Inc. | 2.42 Million USD | 64.765% |
| Vasamed, Inc. | 4.67 Million USD | 81.703% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | 66.625% |
| Yubo International Biotech Limited | 1.25 Million USD | 32.028% |